RNAC

Cartesian Therapeutics (RNAC)

About Cartesian Therapeutics (RNAC)

Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company is headquartered in Gaithersburg, MD.

Details

Daily high

$6.60

Daily low

$6.39

Price at open

$6.50

52 Week High

$20.00

52 Week Low

$5.98

Market cap

169.0M

Dividend yield

0.00%

Volume

63,232

Avg. volume

96,667

P/E ratio

-.12

Cartesian Therapeutics News